# Milestone Pharmaceuticals Inc.: Form 8-K, filed Sep 4, 2024

- Company: [Milestone Pharmaceuticals Inc.](/companies/mist.md) (CIK 1408443)
- Form: 8-K
- Filed: 2024-09-04
- Accepted by EDGAR: Sep 4, 2024, 08:07 ET
- Period: 2024-08-28
- Accession: 0001104659-24-096648
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1408443/000110465924096648/tm2423263d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1408443/000110465924096648/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 5.07: Shareholder vote results
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1408443/000110465924096648/tm2423263d1_8k.htm

Filed Sep 4, 2024.
Source: SEC EDGAR, the filing index for accession 0001104659-24-096648. Last ingested by Listed: Nov 14, 2026, 11:16 ET. No prices; not investment advice.
